DK0460232T3 - Tumorcellevækstinhibitor - Google Patents
TumorcellevækstinhibitorInfo
- Publication number
- DK0460232T3 DK0460232T3 DK91900944.9T DK91900944T DK0460232T3 DK 0460232 T3 DK0460232 T3 DK 0460232T3 DK 91900944 T DK91900944 T DK 91900944T DK 0460232 T3 DK0460232 T3 DK 0460232T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell growth
- tumor cell
- growth inhibitor
- alpha
- weight
- Prior art date
Links
- 239000003966 growth inhibitor Substances 0.000 title abstract 2
- 230000004565 tumor cell growth Effects 0.000 title abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 3
- 108010038807 Oligopeptides Proteins 0.000 abstract 3
- 229940061720 alpha hydroxy acid Drugs 0.000 abstract 3
- 150000001280 alpha hydroxy acids Chemical class 0.000 abstract 3
- 229920000642 polymer Polymers 0.000 abstract 3
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical group OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000003381 stabilizer Substances 0.000 abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1332870A JP2997488B2 (ja) | 1989-12-25 | 1989-12-25 | 腫瘍細胞増殖抑制剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0460232T3 true DK0460232T3 (da) | 1998-04-14 |
Family
ID=18259725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91900944.9T DK0460232T3 (da) | 1989-12-25 | 1990-12-21 | Tumorcellevækstinhibitor |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5972879A (ru) |
| EP (1) | EP0460232B1 (ru) |
| JP (1) | JP2997488B2 (ru) |
| KR (1) | KR920700671A (ru) |
| AT (1) | ATE164075T1 (ru) |
| AU (1) | AU635802B2 (ru) |
| CA (1) | CA2044621A1 (ru) |
| DE (1) | DE69032158T2 (ru) |
| DK (1) | DK0460232T3 (ru) |
| ES (1) | ES2113370T3 (ru) |
| NO (1) | NO913322L (ru) |
| RU (1) | RU2034564C1 (ru) |
| WO (1) | WO1991009612A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1219616A4 (en) | 1999-09-20 | 2002-11-06 | Amato Pharm Prod Ltd | PROCESS FOR THE PREPARATION OF CYCLIC LACTIC ACID OLIGOMERS |
| JP2002275256A (ja) * | 2001-03-19 | 2002-09-25 | Tendou Seiyaku Kk | 乳酸オリゴマーの製造方法 |
| RU2283654C1 (ru) * | 2005-03-30 | 2006-09-20 | Борис Владимирович Афанасьев | Способ получения ростовых факторов белковой природы, ростовой фактор белковой природы и ингибитор пролиферации фибробластов |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4211769A (en) * | 1977-08-24 | 1980-07-08 | Takeda Chemical Industries, Ltd. | Preparations for vaginal administration |
| EP0115473A3 (de) * | 1983-01-27 | 1987-01-21 | Ciba-Geigy Ag | Substituierte Pyrrolidinonderivate und Verfahren zu ihrer Herstellung |
| FI840260A (fi) * | 1983-01-27 | 1984-07-28 | Ciba Geigy Ag | Pyrrolidinonderivat och foerfarande foer deras framstaellning. |
| EP0127426A1 (en) * | 1983-05-23 | 1984-12-05 | Takeda Chemical Industries, Ltd. | Percutaneous pharmaceutical compositions for external use |
| JPS6023326A (ja) * | 1983-07-18 | 1985-02-05 | Takeda Chem Ind Ltd | ペプチド含有経口投与製剤 |
| DE3428372A1 (de) * | 1984-08-01 | 1986-02-13 | Hoechst Ag, 6230 Frankfurt | Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen |
| JPS6163613A (ja) * | 1984-09-04 | 1986-04-01 | Mitsui Toatsu Chem Inc | 顆粒状に調整された徐放性製剤 |
-
1989
- 1989-12-25 JP JP1332870A patent/JP2997488B2/ja not_active Expired - Fee Related
-
1990
- 1990-12-21 AU AU69127/91A patent/AU635802B2/en not_active Ceased
- 1990-12-21 WO PCT/JP1990/001678 patent/WO1991009612A1/ja active IP Right Grant
- 1990-12-21 AT AT91900944T patent/ATE164075T1/de not_active IP Right Cessation
- 1990-12-21 DK DK91900944.9T patent/DK0460232T3/da active
- 1990-12-21 EP EP91900944A patent/EP0460232B1/en not_active Expired - Lifetime
- 1990-12-21 CA CA002044621A patent/CA2044621A1/en not_active Abandoned
- 1990-12-21 ES ES91900944T patent/ES2113370T3/es not_active Expired - Lifetime
- 1990-12-21 DE DE69032158T patent/DE69032158T2/de not_active Expired - Fee Related
- 1990-12-21 US US07/700,158 patent/US5972879A/en not_active Expired - Fee Related
- 1990-12-21 KR KR1019910700779A patent/KR920700671A/ko not_active Application Discontinuation
-
1991
- 1991-08-23 NO NO91913322A patent/NO913322L/no unknown
- 1991-08-23 RU SU915010005A patent/RU2034564C1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH03193731A (ja) | 1991-08-23 |
| AU635802B2 (en) | 1993-04-01 |
| ES2113370T3 (es) | 1998-05-01 |
| WO1991009612A1 (fr) | 1991-07-11 |
| DE69032158D1 (de) | 1998-04-23 |
| DE69032158T2 (de) | 1998-08-06 |
| KR920700671A (ko) | 1992-08-10 |
| NO913322D0 (no) | 1991-08-23 |
| AU6912791A (en) | 1991-07-24 |
| EP0460232A4 (en) | 1993-03-17 |
| EP0460232B1 (en) | 1998-03-18 |
| JP2997488B2 (ja) | 2000-01-11 |
| ATE164075T1 (de) | 1998-04-15 |
| RU2034564C1 (ru) | 1995-05-10 |
| NO913322L (no) | 1991-08-23 |
| EP0460232A1 (en) | 1991-12-11 |
| CA2044621A1 (en) | 1991-06-26 |
| US5972879A (en) | 1999-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE81459T1 (de) | Verwendung von salzen der n-acetylneuraminsaeure zur herstellung eines arzneimittels zum abschwellen der nasenschleimhaut. | |
| CO4440626A1 (es) | Amidas terapeuticas | |
| ES2086341T3 (es) | Derivados de aminoacidos con propiedades inhibidoras de la renina, procedimiento para su preparacion, agentes que los contienen y su utilizacion. | |
| BG46451A3 (en) | Herbicide means | |
| ATE121754T1 (de) | Vakzine gegen bordetella. | |
| NO895002L (no) | Enzymhemmende aminosyrederivater. | |
| DK515288D0 (da) | Fremgangsmaade til syntese af alpha-n-alkylerede aminosyrer og estere deraf | |
| DK0460232T3 (da) | Tumorcellevækstinhibitor | |
| DE69316382D1 (de) | Herstellung von derivaten von n-acetyl neuraminicsäure | |
| ATE84220T1 (de) | Injektionszusammensetzung, die modifiziertes tpa enthaelt. | |
| DK0407815T3 (da) | Præparat indeholdende polyprenylforbindelser til bløde kapsler | |
| ATE28447T1 (de) | Amino- und diaminosaeurederivate, enthaltende gemische und deren verwendung als pflanzenwachstumsfoerderer. | |
| DK0404750T3 (da) | Vævsinhibitor for metalloproteaser | |
| ATE149354T1 (de) | Pharmazeutische zusammensetzung von stabilisiertem (leu 13>-motilin-hse | |
| CA2154668A1 (en) | Condensed heterocyclic glutamic acid derivatives as antiproliferative agents | |
| EP0294668A3 (en) | (2-cyano-2-oximinoacetyl)-amino acid derivatives | |
| SG133594G (en) | Process for racemization of an optically active amino acid amide | |
| DE68908958D1 (de) | Peptide. | |
| JPS5639800A (en) | Method for specific quantitative analysis of pyruvic acid | |
| ES472989A1 (es) | Un metodo para producir un d-x-aminoacido |